Sentences with phrase «on stem cell labs»

In science news around the world, the U.S. Food and Drug Administration (FDA) cracks down on stem cell labs, Brazil opens one of its largest national reserves to gold and iron mining, and the International Atomic Energy Agency launches a global bank for low - enriched uranium.

Not exact matches

Lab - grown tissues derived from patients» stem cells may also allow researchers to screen drugs and test their effectiveness on diseases like cancer.

But the next big question was whether these cells could home in on tumors in lab dishes, and in animals, like neural stem cells.

Culturing stem cells by day, and audiences in dingy stand - up clubs by night, it wasn't until Helen Pilcher left the lab that she started basing her comedy on science.

Research on lab animals has shown that the number of hypothalamus stem cells diminishes with age.

He ruled that work on existing embryonic stem cell lines derived outside federally funded labs did not violate a ban on the destruction of embryos.

An unusual lawsuit filed last month sheds light on a scientific misconduct investigation into a prominent cardiac stem cell lab.

The two - part approach netted a set of mutations seen only at relapse that enabled the team to sift and sort leukemic and normal stem cells using tools developed in the Dick lab a few years ago to zero in on specific cell types fated to relapse.

I couldn't resist composing this after the mention of the charmingly misspelled word «hematopoetic» in your story on blood grown in the lab from stem cells (12 November, p 8):

The problem follows close on the heels of Hwang's admission that, despite his previous denials, two members of his lab had donated oocytes for his group's stem cell experiments and other donors had been paid for their donations (Science, 2 December, p. 1402).

The UK also offers a favorable funding and regulatory climate, says Minger, whose lab works on the therapeutic and clinical applications of stem cell research.

More cautious researchers would have realized they were on the wrong track, says Rudolf Jaenisch, a stem cell researcher at the Massachusetts Institute of Technology in Cambridge whose lab spent 2 months trying to make STAP cells and contributed data to the new paper.

The researchers used the new lab - on - a-chip to study how adult stem cells in adipose tissue develop into mature fat cells, conducting their investigations outside the body.

Last May in Nature Neuroscience, his lab and a team at Columbia University reported that embryonic stem cells could be used to shed light on the origins of amyotrophic lateral sclerosis (ALS), the progressive neurodegenerative disease in which motor neurons in the brain die.

To read more in detail about research on stem cells done in different labs around the world (the Netherlands, UK, US, and elsewhere) click here.

The Food and Drug Administration approved the trial in January 2009 but put it on hold last September because of safety concerns after lab animals injected with stem cells developed small cysts at the injury site.

Scientists have suggested that such embryonic stem cells could be used for learning about genetic diseases, testing new drugs on cells grown in the lab, or growing healthy cells for therapeutic transplantation.

Other labs are already trying to replicate the work, and some have posted their experiences on a stem cell blog.

I've still kept my own lab going focusing on understanding what pluripotent stem cells really are, and the extrinsic signals that govern their self - renewal and differentiation.

Zhang lab Web site Reubinoff lab Web site PNAS abstract on getting blood cells from stem cells Background on stem cells, from the National Institutes of Health

«This is essentially a recipe for how to make human inner ears from stem cells,» said Dr. Koehler, lead author of the study and whose research lab works on modeling human development.

A major concern about stem cells centers on how unstable they can become when grown in the lab.

The Humphreys Lab collaborated with fellow Harvard Stem Cell Institute member Benjamin Ebert, MD, also at Brigham and Women's Hospital, on the work.

The Zeng lab is making great progress on developing a stem cell - derived treatment for Parkinson's disease for testing in humans.

Dr. Melton's lab has been working on getting «a molecular biography,» he said, of all the genetic steps required to make a stem cell a beta cell.

Now, a new STEM CELLS study from the labs of Qing - Ling Fu (Sun Yat - sen University, Guangzhou) and Zhongquan Qi (Xiamen University, Fujian, PR China) has described the effect of iPSC - MSCs on immune T cells in a relevant in vivo mouse mCELLS study from the labs of Qing - Ling Fu (Sun Yat - sen University, Guangzhou) and Zhongquan Qi (Xiamen University, Fujian, PR China) has described the effect of iPSC - MSCs on immune T cells in a relevant in vivo mouse mcells in a relevant in vivo mouse model.

Recently, his lab used induced pluripotent stem (iPS) cells — adult cells made to act like embryonic stem cells — made from skin cells of patients carrying apoE4, or other mutations related to Alzheimer's, to study their effects on the development, survival, and degeneration of human neurons.

The following questions and answers have been paraphrased from a conversation with Prof. Lorenz Studer on October 11th, 2017 discussing the stem cell trials his lab is set to begin in 2018.

More recently, scientists including Benjamin Spike, a co-first author on the current work and post-doctoral fellow in the Wahl lab, have discovered that tumors often contain cells with stem cell characteristics revealed by their genetic signatures.

All the projects in the lab now are focused on trying to use stem cells, or other progenitors, to find new treatments for diabetes.

Very interesting article... I find myself amazed at how much work one or two labs can churn out to advance our understanding — Perhaps you could do a post on current Stem Cell centers around the world, and how much man - power and budget is being devoted to them?

The first of this week's review articles from the lab of Umberto Galderisi (Campania University, Naples, Italy) discusses the effects of low dose ionizing radiation (LDIR) on the biology of stem cell compartments.

Our final review article, from the labs of Maximilian Boesch (Kantonsspital St. Gallen, Switzerland) and Andreas Seeber (Medical University of Innsbruck, Austria), provides an update on the role of epithelial cell adhesion molecule (EpCAM) in cancer stem cells (CSCs) and the epithelial ‐ to ‐ mesenchymal transition (EMT) in colorectal cancer (CRC).

The Ellerby lab is known for its pioneering studies on Huntington's disease (HD), and Karen is now using human stem cell models of HD to understand why important molecular signaling pathways, such as the TGF - β pathway, are dysregulated in HD.

Chunhui Xu's lab in the Department of Pediatrics recently published a paper in Stem Cell Reports on the differentiation of endothelial cells, which line and maintain blood vessels.

In addition to its emphasis on producing vaccines, the lab specializes in gene and cell therapies, including stem cell products.

Right now, stem cell products are commonly produced on a very small scale to use in lab experiments, but we need to make them in much greater orders of magnitude for use in future human therapies.

Her lab focuses on the regulation and therapeutic potential of blood and muscle stem cells.

Distilling the most radical accomplishments being made in labs worldwide, including gene therapy, genetic engineering, stem cell research, life extension, brain - computer interfaces, and cloning, More Than Human offers an exciting tour of the impact biotechnology will have on our lives.

Schnabel's research lab primarily focuses on equine stem cell immunology and other regenerative therapies for musculoskeletal injuries and diseases.

Currently, her lab is focused on finding drugs suitable for eliminating mammary cancer and ocular herpevirus infections in small companion animals, and evaluating the effectiveness of stem cell therapies for treating skin wounds in horses — all of which may also be used in humans and other animals.

And meanwhile, university researchers can and do work on embryonic stem cells — just so long as they don't use federal funds (which makes for some complicated partitioning of lab equipment in many a US university department).